Publication | Closed Access

Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment

Surgical OncologyBreast OncologyMedicineCancer RecurrenceSystemic TreatmentLocoregional Recurrence RiskPathologyBreast CancerBreast SurgeryT1,2 Breast CancerOncologyRadiation Oncology